The treatment, developed by Awakn Life Science, was administered today in New York City at the Nushama ketamine clinic.
A jury in Monterey California has returned a verdict that found MAPS liable in a wrongful death lawsuit.
After a three-week trial, a jury found MAPS partially responsible for the wrongful death of a woman cared for in the Zendo Project peer support space and liable for damages.
A first-of-its-kind review suggests that regular treatments are effective at reducing risk of relapse, though researchers say more study is needed.
The MAPS nonprofit faces a jury trial next week to address a lawsuit brought by the family of a woman who died after being at the Zendo care space at a music festival in 2017.
The legendary pioneer of psychedelic-assisted therapy leaves behind a legacy of wisdom for healers and explorers of the subconscious.
As the need for psychedelic therapists expands, more training programs emerge to meet the needs of patients.
Researchers are exploring possible causal links between use of magic mushrooms and opioid dependency.
If proven safe and effective in humans, such “no-trip psychedelics” could potentially deliver relief from depression and other mental health conditions to millions more people than could traditional psychedelics.